Headquartered in Brandon, FL, privately-held Jointechlabs is an emerging worldwide leader in regenerative medicine.
The company enables healthcare practitioners to provide safe, cost-effective, non-surgical therapies at the point-of-care without change in infrastructure.
FDA-cleared MiniTC® is a stand-alone device for processing autologous fat into regenerative-cell-rich microfat. Microfat’s uses include a variety of orthopedic, aesthetic, wound healing, and reconstructive surgery applications. Additionally, in certain markets, CE-Mark-approved Mini-Stem System® extracts microfat and Stromal Vascular Fraction. Pipeline includes development of stem-cell based therapeutics with 3D Bioprinted constructs and injectable stem cell scaffolding.
Posts attributed to Jointechlabs may have been written by one or more staff members, consultants, or third parties.
More Information: https://www.jointechlabs.com.
Home Page: https://jointechlabs.com
Jointechlabs has been granted a core Chinese patent and has entered into a joint venture to develop the microfat market in China.
Dr. Nathan Katz discusses best practices in microfat-based procedures and the processing of microfat for optimal results.
Jointechlabs has released new components and standardized processing to reduce time, complexity, and cost of microfat-based regenerative medicine procedures.
New syringes and a choice of cannulas will make adipose processing faster and personalized to each physician’s needs.
Jointechlabs earned the MDSAP quality certification indicating compliance with ISO13485:2016 for medical device quality management.
European focus includes a new subsidiary in Austria, a medical research center in partnership with a prominent health center, and development and distribution agreements for Germany, Austria, Switzerland, Italy, Spain, and the Balkans.
Jointechlabs has just strengthened its intellectual property position with the granting of a new US patent covering systems and methods of encapsulating stem cells.
Drs. Katz and Guarino demonstrate the operation of MiniTC.
Catarina Hadamitzky, Tatiana S. Zaitseva, Nathan Katz, Claire P Edelstein, Manuel T. Escarraman, Dung Nguyen, Michael V. Paukshto Clinic of Plastic, Aesthetic and Hand Surgery, Helios Clinic, Hildesheim, Germany. Fibralign Corporation, Union City, California, USA. JointechLabs, Inc, N. Barrington, Illinois, USA. Instituto Oncológico Dr. Heriberto Pieter, Santo Domingo, Dominican Republic. Department of Plastic Surgery, Stanford […]
Critical skin wounds are a major cost for the health sector and lead to immense suffering for the patients. One way to facilitate the healing of these wounds is through autologous adipose tissue transplants. However, the implanted tissue needs to be vascularized or it will suffer from necrosis. To combat this Stromal vascular fraction (SVF), […]